Our Masters of Research (MRes) in Translational Medicine provides high-quality research and training skills for students who want to use state-of-the-art biotechnologies to rapidly translate disease research into improved clinical healthcare.
With advances in technology, graduates are now faced with heightened expectations to conduct effective bioscience research. Employers demand skillsets comprising biological, medical, physical and computational characteristics and this Masters is designed to provide this breadth of training.
The core aim is to train the next generation of scientists able to 'fast-track' biological and scientific data into advanced therapies and diagnostics tools.
Our understanding of the molecular basis of disease and drug mechanisms has improved dramatically in recent years, yet there is a distinct shortage of individuals able to apply this knowledge into effective clinical benefit.
Our MRes in Translational Medicine (Interdisciplinary Molecular Medicine) provides intense training in 'omics' skills and techniques such as genetics, genomics, transcriptomics, proteomics and metabolomics.
The training in metabolomic techniques is novel for a UK course, and teaching on the integration of different omic platforms and data in a systems medicine strategy is unique.
With its extended 35-week research project and broad training in biotechnology for medical healthcare, this MRes provides an excellent platform to progress into PhD research, or for a career in academia or the pharmaceutical or biotechnology industries, or as a clinical academic.
The MRes has substantial interdisciplinary focus; training comprises four taught modules before you undertake an extended 35-week research project within The University of Manchester, Waters or one of the Greater Manchester teaching hospitals.
A wide choice of projects are available (view the list of example projects), allowing individuals to focus on areas of interest such as the use of gene expression profiling, proteomics, metabolomics, stem cell research, tissue culture or pharmacogenetics in the biology of cancer, cardiovascular disease, infectious diseases, stroke or diabetes.
The MRes lasts for one year full-time, so it provides the ideal opportunity to experience the challenges of multidisciplinary research first-hand before committing to further training.
Over 85% of our graduates secure further research (PhD), pharmaceutical or biotechnology industry, or medical training posts upon completion.
Prestigious MRC studentships are available to candidates seeking entry on the Master of Research (MRes) in Translational Medicine (Interdisciplinary Molecular Medicine) in September 2015. Studentships provide full support for tuition fees in addition to a tax-free minimum stipend at Research Council rates (£13, 863 in 2014/15).The MRes Translational Medicine (MRes TM) aims to train the next generation of scientists able to 'fast-track' biological and scientific data into advanced therapies and diagnostic tools. Our understanding of the molecular basis of disease and drug mechanisms has improved dramatically in recent years, yet there is a distinct shortage of individuals able to apply this knowledge into effective clinical benefit. Employers now demand skill-sets comprising biological, medical, physical and computational characteristics.The MRes TM seeks to address this by providing intensive training in 'omics' skills and techniques such as genetics, transcriptomics, proteomics and metabolomics. The MRes differs from other UK based biomolecular courses by taking a unique 'systems medicine' approach to these different 'omic' platforms and data. The emphasis is not simply upon equipping students with knowledge and understanding of biomedical technologies, but their longer-term application in order to 'translate' bench-to-bedside research.With an extended 35-week research project, and advanced research and quantitative methods training provided, the MRes is ideally placed to equip graduates to progress into PhD research, pharmaceutical/biotechnology R&D or a clinical academic career. Our students benefit from cutting-edge research facilities and the wealth of expertise and support available from eminent and early-career scientists.Applications for MRC funding are welcomed up to and including 31 May 2015. Places for 2015 entry are limited so early application is encouraged. Individuals wishing to be considered for entry onto the MRes and MRC support should follow the application guidance below.Studentships are available to UK/EU* applicants who hold or expect to be awarded a 1st or 2i (or equivalent) in a relevant biological or medical subject. Any enquiries should be directed to Dr John Curtin ([email protected]).
Value of Scholarship(s)
Annual tax-free stipend (£13, 863 in 2014/15) plus full support for tuition fees
Applicants for these MRC studentships must be UK/EU nationals who have been permanent residents of the UK since at least 1 September 2012. EU nationals who do not meet the UK residency requirement are eligible for studentships providing tuition fee support only.
Please refer to the MRes website for full application details:
We require an honours degree (minimum Upper Second) in the biomedical, medical, biological, chemical, biochemical or pharmacological sciences or in medicine, dentistry or veterinary medicine from a recognised university. We will also consider candidates with Upper Second degrees in a relevant analytical, physical or computing science area. Candidates on the undergraduate medical programme must have satisfactorily completed Years 1 to 3 of the MBChB. For St Andrews students, this includes the 3-year degree programme and the following year spent in Manchester (Year 3 of the Manchester programme).
Fee information is provided on the University of Manchester website
Recipient: University of Manchester
Insert previous message below for editing?
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need. Why not add a message here